Assignee
INTARCIA THERAPEUTICS INC
US·49 granted patents·23 pending applications·948 citations·filing 2003–2023
Top patents by PatentIndex Score
72 records- 0199US7682356B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2007·Granted Mar 23, 2010·84 cites·22 claims
- 0298US8992962B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2013·Granted Mar 31, 2015·29 cites·49 claims
- 0398US8372424B2Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2012·Granted Feb 12, 2013·81 cites·21 claims
- 0498US8367095B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2012·Granted Feb 5, 2013·33 cites·28 claims
- 0597US9526763B2Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2015·Granted Dec 27, 2016·24 cites·20 claims
- 0697US7919109B2Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2008·Granted Apr 5, 2011·35 cites·20 claims
- 0797US7316680B2Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channelINTARCIA THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·35 cites·8 claims
- 0896US9682127B2Osmotic delivery device comprising an insulinotropic peptide and uses thereofINTARCIA THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·21 cites·30 claims
- 0996US9539200B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2015·Granted Jan 10, 2017·23 cites·24 claims
- 1096US9095553B2Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2012·Granted Aug 4, 2015·27 cites·17 claims
- 1196US8052996B2Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2007·Granted Nov 8, 2011·37 cites·17 claims
- 1296US8048438B2Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2008·Granted Nov 1, 2011·35 cites·20 claims
- 1396US7959938B2Polyoxaester suspending vehicles for use with implantable delivery systemsINTARCIA THERAPEUTICS INC·Filed 2006·Granted Jun 14, 2011·37 cites·18 claims
- 1496US7879028B2Osmotic delivery systems and piston assemblies for use thereinINTARCIA THERAPEUTICS INC·Filed 2010·Granted Feb 1, 2011·72 cites·16 claims
- 1596US7655257B2Sustained delivery of an active agent using an implantable systemINTARCIA THERAPEUTICS INC·Filed 2003·Granted Feb 2, 2010·50 cites·23 claims
- 1695US9889085B1Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1cINTARCIA THERAPEUTICS INC·Filed 2015·Granted Feb 13, 2018·18 cites·23 claims
- 1794US9572889B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2014·Granted Feb 21, 2017·23 cites·63 claims
- 1894US8343140B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2009·Granted Jan 1, 2013·30 cites·20 claims
- 1994US7964183B2Composition and dosage form comprising a particle formulation and suspending vehicleINTARCIA THERAPEUTICS INC·Filed 2009·Granted Jun 21, 2011·28 cites·22 claims
- 2093US7731947B2Composition and dosage form comprising an interferon particle formulation and suspending vehicleINTARCIA THERAPEUTICS INC·Filed 2004·Granted Jun 8, 2010·46 cites·24 claims
- 2193US7407499B2Osmotic pump with self-retaining, fast-start membrane plugINTARCIA THERAPEUTICS INC·Filed 2004·Granted Aug 5, 2008·39 cites·19 claims
- 2290US11840559B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·1 cites·19 claims
- 2389US11739134B2Long acting peptide tyrosine tyrosine (PYY) analogs and methods of useINTARCIA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·2 cites·20 claims
- 2487US11214607B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jan 4, 2022·3 cites·20 claims
- 2586USD840030SImplant placement guideINTARCIA THERAPEUTICS INC·Filed 2016·Granted Feb 5, 2019·25 cites·1 claims
- 2685US7655254B2Implantable device for continuous delivery of interferonINTARCIA THERAPEUTICS INC·Filed 2006·Granted Feb 2, 2010·44 cites·33 claims
- 2784US10501517B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·4 cites·61 claims
- 2883US11654183B2Methods comprising continuous administration of exenatide and co-administration of a drugINTARCIA THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·1 cites·14 claims
- 2983US7727519B2Method for treating hepatitis C virus with omega interferonINTARCIA THERAPEUTICS INC·Filed 2004·Granted Jun 1, 2010·34 cites·22 claims
- 3079US7011851B2Oxidized collagen formulations for use with non-compatible pharmaceutical agentsINTARCIA THERAPEUTICS INC·Filed 2003·Granted Mar 14, 2006·14 cites·9 claims
- 3178US10159714B2Compositions, devices and methods of use thereof for the treatment of cancersINTARCIA THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·2 cites·8 claims
- 3275US12122816B2Long acting peptide tyrosine tyrosine (PYY) analogs and methods of useINTARCIA THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·25 claims
- 3375US10925639B2Implant placement and removal systemsINTARCIA THERAPEUTICS INC·Filed 2016·Granted Feb 23, 2021·2 cites·26 claims
- 3474US12042557B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2020·Granted Jul 23, 2024·0 cites·24 claims
- 3569US2017319662A1Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3669US2008269726A1Osmotic pump with self-retaining, fast-start membrane plugINTARCIA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3769US2009087408A1Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable deviceINTARCIA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3868US2017119855A1Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehiclesINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3966US12084485B2Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of useINTARCIA THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·28 claims
- 4066US12018059B2Human amylin analog polypeptides and methods of useINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jun 25, 2024·0 cites·35 claims
- 4166US10583080B2Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1cINTARCIA THERAPEUTICS INC·Filed 2018·Granted Mar 10, 2020·0 cites·27 claims
- 4266US2020360267A1THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1cINTARCIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4366US2017181964A1Two-piece, internal-channel osmotic delivery system flow modulatorINTARCIA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4466US2017348392A1Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4566US2015057227A1Compositions, devices and methods of use thereof for the treatment of cancersINTARCIA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4665US10441528B2Devices, formulations, and methods for delivery of multiple beneficial agentsINTARCIA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 4765US2008112994A1Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic mediumINTARCIA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 4865US2017056476A1Solvent/polymer solutions as suspension vehiclesINTARCIA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4964US2020397690A1THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1cINTARCIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5063US10869830B2Rapid establishment and/or termination of substantial steady-state drug deliveryINTARCIA THERAPEUTICS INC·Filed 2018·Granted Dec 22, 2020·0 cites·21 claims
Showing the top 50 of 72 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →